Fructooligosaccharides and mannose affect Clostridium difficile adhesion and biofilm formation in a concentration-dependent manner.


Journal

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
ISSN: 1435-4373
Titre abrégé: Eur J Clin Microbiol Infect Dis
Pays: Germany
ID NLM: 8804297

Informations de publication

Date de publication:
Oct 2019
Historique:
received: 18 06 2019
accepted: 09 07 2019
pubmed: 1 8 2019
medline: 15 1 2020
entrez: 1 8 2019
Statut: ppublish

Résumé

The aim of this study was to investigate the effects that prebiotic and candidates for prebiotics on Clostridium difficile strains to adhere to various human epithelial cell lines and to compare the adhesive properties of specific C. difficile strains. We also sought to examine the effect of different concentrations of fructooligosaccharides and mannose on the formation of biofilms by C. difficile strains. The influence of cellobiose, fructooligosaccharides, inulin, mannose, and raffinose on the adherence properties of various C. difficile strains, including motile 630, non-motile M120, and 10 clinical motile ribotype 027 strains, to non-mucous secreting HT-29, mucous secreting HT-29 MXT, and CCD 841 CoN cells lines. The most effective prebiotics were used in biofilm formation assays. We demonstrated that all C. difficile strains adhered to all cell lines. However, the C. difficile M120 non-motile strain was statistically more likely to adhere to all three cell lines (CFU median, 40) compared to the motile strains (CFU median, 3; p < 0.001). Furthermore, among the carbohydrates examined, only fructooligosaccharides and mannose were found to significantly decrease adhesion (p < 0.001) of C. difficile strains. Alternatively, using a biofilm assay, we observed, via confocal laser scanning microscopy, that sub-inhibitory concentrations (1%) of fructooligosaccharides and mannose functioned to increase biofilm formation by C. difficile. We demonstrated that specific prebiotics and candidate prebiotics exhibit varying anti-adhesive properties towards C. difficile in vitro and that treatment with sub-inhibitory concentrations of prebiotics can cause an increase in biofilm formation by C. difficile.

Identifiants

pubmed: 31363870
doi: 10.1007/s10096-019-03635-7
pii: 10.1007/s10096-019-03635-7
pmc: PMC6778530
doi:

Substances chimiques

Anti-Bacterial Agents 0
Oligosaccharides 0
Prebiotics 0
fructooligosaccharide 0
Mannose PHA4727WTP

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1975-1984

Subventions

Organisme : Narodowe Centrum Nauki
ID : UMO:2017/25/N/NZ6/01763

Références

Anaerobe. 2018 Aug;52:100-110
pubmed: 29935270
Nature. 2018 Jan 18;553(7688):291-294
pubmed: 29310122
PLoS One. 2014 Jan 30;9(1):e87757
pubmed: 24498186
Clin Infect Dis. 2010 Jan 15;50(2):194-201
pubmed: 20025526
J Med Microbiol. 1994 Sep;41(3):191-6
pubmed: 8064839
FEBS Lett. 2012 May 21;586(10):1459-65
pubmed: 22673511
BMC Microbiol. 2006 Jul 11;6:60
pubmed: 16834772
Front Microbiol. 2018 Nov 06;9:2707
pubmed: 30459747
Anaerobe. 2016 Jun;39:136-42
pubmed: 27018325
Anaerobe. 2018 Oct;53:2-4
pubmed: 29730161
J Nutr. 1999 Jul;129(7 Suppl):1402S-6S
pubmed: 10395607
Clin Microbiol Infect. 2015 Mar;21(3):248.e9-248.e16
pubmed: 25701178
Crit Rev Food Sci Nutr. 1995 Nov;35(6):525-52
pubmed: 8777017
Foodborne Pathog Dis. 2015 Apr;12(4):360-5
pubmed: 25692734
Infect Immun. 1994 Oct;62(10):4347-55
pubmed: 7927694
J Clin Microbiol. 1999 Feb;37(2):461-3
pubmed: 9889244
FEMS Microbiol Ecol. 2014 Oct;90(1):225-36
pubmed: 25098489
Infect Immun. 2006 Dec;74(12):6920-8
pubmed: 16982832
Nat Rev Microbiol. 2009 Jul;7(7):526-36
pubmed: 19528959
Genome Biol. 2009;10(9):R102
pubmed: 19781061
Cell Rep. 2018 Sep 18;24(12):3087-3098
pubmed: 30231992
Euro Surveill. 2015;20(38):null
pubmed: 26536049
Antimicrob Resist Infect Control. 2017 Jun 3;6:54
pubmed: 28588767
Nat Rev Gastroenterol Hepatol. 2017 Aug;14(8):491-502
pubmed: 28611480
Microbiol Resour Announc. 2018 Sep 27;7(12):null
pubmed: 30533668
Cancer Res. 1990 Oct 1;50(19):6334-43
pubmed: 2205381
J Bacteriol. 2009 Nov;191(22):7050-62
pubmed: 19749038
FEMS Immunol Med Microbiol. 2003 Oct 15;38(3):181-91
pubmed: 14522453
J Pediatr Gastroenterol Nutr. 2009 Apr;48 Suppl 2:S63-5
pubmed: 19300129
Infect Immun. 2012 Oct;80(10):3521-32
pubmed: 22851750
NPJ Biofilms Microbiomes. 2018 Jun 29;4:13
pubmed: 29977590

Auteurs

Michał Piotrowski (M)

Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.

Dorota Wultańska (D)

Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.

Piotr Obuch-Woszczatyński (P)

Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland.

Hanna Pituch (H)

Department of Medical Microbiology, Medical University of Warsaw, Warsaw, Poland. hanna.pituch@wum.edu.pl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH